We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+5.21%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.87%
AUM
$99B
AUM Growth
+$5.31B
Cap. Flow
-$322M
Cap. Flow %
-0.32%
Top 10 Hldgs %
14.08%
Holding
2,651
New
81
Increased
1,135
Reduced
556
Closed
97

Sector Composition

Rank Sector Weight
1 Healthcare 14.05%
2 Technology 13.96%
3 Financials 13.95%
4 Industrials 9.13%
5 Energy 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTNT icon
1251
Fortinet
FTNT
$120B
$2.17M ﹤0.01%
432,725
+9,500
+2% +$42.6K
EAT icon
1252
Brinker International
EAT
$9.69B
$2.16M ﹤0.01%
44,462
+300
+0.7% +$15K
PACW
1253
DELISTED
PacWest Bancorp
PACW
$2.16M ﹤0.01%
49,945
+36,746
+278% +$1.53M
AZZ icon
1254
AZZ Inc
AZZ
$4.57B
$2.15M ﹤0.01%
46,580
+3,227
+7% +$142K
KOS icon
1255
Kosmos Energy
KOS
$1.4B
$2.15M ﹤0.01%
191,045
+16,700
+10% +$179K
TTC icon
1256
Toro Company
TTC
$9.42B
$2.15M ﹤0.01%
67,472
PANW icon
1257
Palo Alto Networks
PANW
$296B
$2.14M ﹤0.01%
153,000
+15,000
+11% +$175K
BKD icon
1258
Brookdale Senior Living
BKD
$3.45B
$2.12M ﹤0.01%
63,606
+4,800
+8% +$156K
KMT icon
1259
Kennametal
KMT
$2.6B
$2.11M ﹤0.01%
45,665
+700
+2% +$32.4K
DAN icon
1260
Dana Inc
DAN
$3.01B
$2.11M ﹤0.01%
86,295
+800
+0.9% +$17.9K
CBOE icon
1261
Cboe Global Markets
CBOE
$29.7B
$2.11M ﹤0.01%
42,793
CXT icon
1262
Crane NXT
CXT
$3.01B
$2.09M ﹤0.01%
81,067
NTGR icon
1263
NETGEAR
NTGR
$654M
$2.09M ﹤0.01%
60,236
-435
-0.7% -$14.5K
INFA
1264
DELISTED
INFORMATICA CORP
INFA
$2.09M ﹤0.01%
58,751
DDS icon
1265
Dillards
DDS
$9.63B
$2.09M ﹤0.01%
17,918
AL
1266
DELISTED
Air Lease Corp
AL
$2.09M ﹤0.01%
54,143
+3,600
+7% +$138K
FNFG
1267
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
$2.08M ﹤0.01%
238,272
-963,500
-80% -$8.53M
ALR
1268
DELISTED
Alere Inc
ALR
$2.08M ﹤0.01%
55,652
+1,200
+2% +$42.7K
LXK
1269
DELISTED
Lexmark Intl Inc
LXK
$2.08M ﹤0.01%
43,204
IEMG icon
1270
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
$2.08M ﹤0.01%
40,187
LPLA icon
1271
LPL Financial
LPLA
$28.3B
$2.07M ﹤0.01%
41,651
+3,429
+9% +$166K
CLGX
1272
DELISTED
Corelogic, Inc.
CLGX
$2.07M ﹤0.01%
68,125
+1,500
+2% +$43.3K
BIG
1273
DELISTED
Big Lots, Inc.
BIG
$2.06M ﹤0.01%
45,145
-200
-0.4% -$8.13K
ZBRA icon
1274
Zebra Technologies
ZBRA
$17.6B
$2.06M ﹤0.01%
25,031
-200
-0.8% -$14.6K
SNV
1275
DELISTED
Synovus
SNV
$2.05M ﹤0.01%
84,109
+2,197
+3% +$51.2K

Similar funds

UBS AM's Q2 2014 Portfolio in Review

As of Q2 2014, UBS AM held 2,651 positions worth $99B, up 5.7% from $93.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS AM's Q2 2014 filing shows 81 new, 1,135 increased, 556 reduced and 97 closed positions. Its largest new stake was Sabre: 3,529,400 shares worth $70.8M. The largest sale was Allergan Inc, an estimated $227M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.

  • UBS AM's largest Q2 2014 buy was Sabre: 3,529,400 shares worth $70.8M.
  • UBS AM added most to Thermo Fisher Scientific in Q2 2014, an estimated $234M increase.
  • UBS AM's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $227M.
  • UBS AM fully exited Freeport-McMoran in Q2 2014, selling an estimated $112M.
  • UBS AM's ten largest holdings make up 14% of its $99B portfolio in Q2 2014.
  • UBS AM opened 81 new positions and closed 97 in Q2 2014.
  • UBS AM's portfolio value rose 5.7% quarter-over-quarter to $99B.

Based on UBS AM's 13F filing for Q2 2014, filed 13 Aug 2014.